| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |